跳至主要内容
临床试验/CTRI/2020/01/022628
CTRI/2020/01/022628招募中未知

Role of Optical Coherence Tomography in early detection of Hydroxychloroquine Retinopathy preceding visual field defects.

Dr Premjith Muraleedharan0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • All patients using Tablet Hydroxychloroquine for more than 12 +/- 3 months

排除标准

  • 1. Patients with any ocular infection, or any other ocular disease like glaucoma, optic nerve and retinal diseases, uveitis, previous ocular surgeries, refractive errors and media opacity
  • (Refractive error greater than +/- 6D sphere or +/- 3D cylindrical)
  • 2. Patients with renal/ liver dysfunction.
  • 3. Patients on concomitant Tamoxifen therapy.
  • 4. Parents not willing to participate.

研究者

发起方
Dr Premjith Muraleedharan

相似试验